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during Administration of Norepinephrine
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Henning B. Nielsen, M.D., D.M.Sc.,§ Matthias Kohl-Bareis, Ph.D., Carsten Lundby, Ph.D., #
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ABSTRACT
Background: Perioperative optimization of spatially resolved
near-infrared spectroscopy determined cerebral frontal lobe oxy-
genation (scO2) may reduce postoperative morbidity. Nor-
epinephrine is routinely administered to maintain cerebral
perfusion pressure and, thereby, cerebral blood flow, but
norepinephrine reduces the scO2. We hypothesized that nor-
epinephrine-induced reduction in scO2 is influenced by cu-
taneous vasoconstriction.
Methods: Fifteen healthy male subjects (25 5 yr, mean
SD)were studied during: hyperventilation (1.5 kPa end-tidal
PcO2 reduction), whole-body heating, administration of nor-
epinephrine (0.15 g  kg1  min1; with and without
end-tidal carbon dioxide correction), and hypoxia (FiO2:
0.12%). Arterial (saO2), skin, and internal jugular venous
oxygen saturations (sjO2) were recorded, and the average ce-
rebral capillary oxygen saturation (scapO2) was calculated.
Results: This study indicates that scO2 is influenced by skin
oxygen saturation because whole-body heating increased
scO2 by 3.6% (2.1–5.1%; 95% CI) and skin oxygen satura-
tion by 3.1% (1.3–4.9%), whereas scapO2 remained unaf-
fected. Conversely, hyperventilation decreased scO2 by 2.1%
(0.4–3.7%) and scapO2 by 5.3% (3.8–6.9%), whereas skin
oxygen saturation increased 1.8% (0.5–3.1%). In response to
hypoxia, scO2 (10.2%; 6.6–13.7%), scapO2 (7.9%; 6.4–9.4%),
and skin oxygen saturation (8.9%; 6.3–11.6%) all decreased.
With administration of norepinephrine there was a 2.2% (1.0–
4.3%) decrease in skin oxygen saturation and scO2 decreased
6.2% (4.2–8.0%), with scapO2 remaining unaffected.
Conclusion:The results confirm that spatially resolved near-
infrared spectroscopy detects cerebral deoxygenation with
systemic hypoxic exposure and hyperventilation. However, a
commonly used vasopressor norepinephrine disturbs skin
oxygen saturation to an extent that influences scO2.
I T is crucial to maintain cerebral blood flow (CBF) duringanesthesia, but it is difficult to determine CBF in clinical
settings. On the other hand, it is straightforward to monitor
frontal lobe oxygenation (scO2) by noninvasive near-infrared
spectroscopy (NIRS) that provides real-time assessment and
is reported to monitor scO2 correctly.
1 Thus, perioperative
optimization may be directed to preserve scO2
2 and main-
tained scO2 secures rapid postoperative recovery in both car-
diac3 and elderly patients.4 For example, vasopressors are
administered to prevent reductions in mean arterial pressure
(MAP) that could affect CBF and in turn scO2. However,
vasopressors appear to affect scO2 differently. Phenylephrine
reduces scO2 in anesthetized patients,
5 but that is not the case
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What We Already Know about This Topic
• Cerebral oximetry by spatially resolved near-infrared spectros-
copy is used to monitor and optimize cerebral oxygenation
during procedures that might impair cerebral perfusion
• Changes in cutaneous perfusion could interfere with the accu-
racy of cerebral oximetry
What This Article Tells Us That Is New
• The effects of hypocapnia, hyperthermia, hypoxia, and norepi-
nephrine on cerebral and forehead skin blood flow and oxy-
genation were studied in human volunteers
• Cerebral oximetry accurately detected cerebral deoxygenation
produced by hypoxia and hyperventilation, but hyperthermia
and norepinephrine affected skin oxygenation and directionally
influenced cerebral oximetry readings
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for ephedrine.6 In healthy subjects the administration of norepi-
nephrine reduces scO2
7 with a concomitant reduction in blood
flow velocity in the middle cerebral artery (MCA vmean) and
internal jugular venous saturation (sjO2), suggesting that
sympathetically mediated cerebral vasoconstriction reduces
CBF to an extent that affects scO2. But sympathetic inner-
vation of the cerebral vasculature remains controversial,
and whether administration of norepinephrine reduces
MCA vmean remains debated.
8 Alternatively, the reduction in
scO2 following administration of norepinephrine is influ-
enced by cutaneous vasoconstriction.9 Also both CBF and
scO2 are sensitive to changes in PaCO2
10,11 and an increase in
ventilation provoked by administration of norepinephrine
could contribute to the reduction in scO2.
12
An influence from skin oxygenation to the NIRS signal
has been identified.13,14 In a hot environment, skin blood
flow (SBF) increases, especially over the forehead,15 whereas
there is no change in CBF or muscle blood flow. However,
the NIRS-determined muscle oxygenation increases during
whole-body heating.13 For evaluation of cerebral oxygen sat-
uration in a hot environment, it appears important that hy-
perthermia elicits a hyperventilation-induced lowering of
PaCO2
16,17 and, in turn, CBF.18 Thus, when scO2 is unaf-
fected by hyperthermia19 while the internal jugular venous-
derived cerebral oxygenation is reduced,20 the maintained
scO2 indicates that scO2 is influenced by SBF, and this hy-
pothesis was tested in the present study. For this purpose we
assessed cerebral perfusion and oxygenation while PaCO2 and
PaO2 were manipulated with separate assessment of SBF and
skin hemoglobin and oxygenation.
Materials and Methods
Fifteen healthy males (age 25  5 yr [mean  SD], height
182 7 cm, and mass 76 8 kg) participated in the study.
The study was approved by the local ethics committee
(H-4–2010–132, Copenhagen, Denmark) in accordance
with Declaration of Helsinki including oral and written in-
formed consent.
After arrival to the laboratory at 8:00 AM, the subjects were
resting supine for 20 min before catheterization. Under local
anesthesia (2% lidocaine), a catheter (Edwards Life Sciences,
Irvine, CA) was inserted retrograde in the right internal jug-
ular vein by Seldinger technique guided by ultrasound, and
the tip of the catheter was placed at its bulb. The position of
the catheter at the jugular bulb was verified during placement
if the subjects reported a slight pain behind the ear. The
placement was also confirmed by quick infusion of saline if
the subject experienced an auditory response.21,22 A 20 G
catheter was placed in the brachial (n  12) or radial artery
(n 3) of the nondominant arm and a central venous cath-
eter (Cavafix MT134, Braun, Melsungen, Germany) was
advanced through an arm vein. Catheters were connected to
transducers (Edwards Life Sciences) placed at the level of the
heart (fourth intercostal space; Dialogue-2000; IBC-Danica
Electronic, Copenhagen, Denmark) to monitor MAP and
heart rate. Data were analog-digital converted and sampled at
200 Hz (DI-720; Dataq Instruments Inc., Akron, OH) by
computer software (Windaq; Dataq Instruments Inc.).
To assess scO2 we used a spatially resolvedNIRS (INVOS;
Somanetics, Troy, MI), meaning that it records differences
in absorption of photons returning from deep and superficial
tissues23 using light at 703 and 808 nm and an emitter-
detector separation of 3 and 4 cm with the depth sensitivity
corresponding to approximately one-third of the emitter-
detector separation.24 Although the algorithm of the instru-
ment is not disclosed, the apparatus is widely used in clinical
cerebral monitoring2,3,10,25 and evaluation of its perfor-
mance is therefore important. The general approach of this
instrumentation is that by analyzing the signals from the two
emitter-detector separations, the signal of superficial tissue
layers is suppressed, providing an estimate of deep tissue, e.g.,
the frontal lobe oxygenation. We assumed that frontal lobe
activation was unchanged throughout the protocol and
therefore did not influence cerebral metabolic rate of oxygen
and, in turn, the NIRS signal. To avoid any influences from
the frontal or sagittal sinuses to the NIRS signal, the sensor
was placed high on the forehead in randomized and balanced
order. The SBF was monitored by LDF (moorVMS-LDF;
Moor Instruments, Axminster, United Kingdom) using light
at 785 nm. The LDF sensor was integrated with a tissue
oxygenation sensor (moorVMS-OXY; Moor Instruments)
that uses white light spectroscopy (wavelength range, 400–
700 nm) to assess skin oxygen saturation, skin hemoglobin
concentrations, and temperature. The instrument self-cali-
brates when turned on prior and LDF and white light spec-
troscopy are established as valid measurements of the micro-
circulation of the skin.26,27 We assumed that changes in SBF
beneath the LDF sensor reflected that beneath the NIRS
sensor, with the two sensors placed ipsilateral and distanced 3
to 4 cm apart.
To evaluate whether the interventions affected CBF,
MCA vmean was determined by transcranial Doppler sonog-
raphy (2MHz probe,Multi-Dop,DWL, Singen, Germany).
Using adhesive ultrasound gel, the best signal-to-noise ratio
was obtained at the temporal insonation window. Placement
of the probe was randomized and balanced across subjects
with respect to hemisphere, and eight subjects had the probe
placed on the right side. Previous reports exclude influence of
PaCO2 on the diameter of the MCA and we, therefore, as-
sumed that changes in MCA vmean reflect those in CBF.
28
Transcranial Doppler, SBF, NIRS, and skin oxygenation
in addition to the blood pressure signals were all analog-
digital converted and sampled on the DI-720. Following
recording, values were averaged over at least 30 s before en-
tering the statistical analysis.
Arterial and jugular venous blood samples were obtained
simultaneously in preheparinised syringes. Atmospheric air
was immediately removed from the syringe. The samples
were analyzed for PaO2 and PaCO2, oxygen saturation (saO2;
sjO2), and total hemoglobin (ABL700; Radiometer, Copen-
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hagen, Denmark). To express the oxygen content in the ar-
terial or venous blood,CO2  0.0031  PO2  Hb  SO2was
used. The arterial to venous difference (avdO2) for the brainwas
calculated. With the assumption that CMRO2 was constant,
changes in CBF were calculated using the Fick equation,
CBFFICK 
1
avdO2
.
The cerebrovascular resistance index was calculated as MAP
divided by MCAvmean and the skin vascular resistance index
was MAP divided by SBF. Using a simplified equation,
scapO2 was calculated:
1,29
scapO2
saO2 sjO2
2
.
The calculation of scapO2 is based on the cerebral oxygen
extraction and motivated by the assumption that oxygen ex-
traction remains constant along the capillary network.30,31
Gas is exchanged linearly along the entire vascular pathway
from the arteries to the veins.32,33 Thus, it can be assumed
that sO2 decreases linearly from the arterial to the venous end
of the capillary and average cerebral oxygen saturation is then
the midway point between arterial and venous saturations.29
Protocol
Following catheterization, the subjects rested supine for 30
min with elevated head rest with room temperature kept
constant (22–24°C). The experiment included three trials
performed in randomized and balanced order, followed by a
hypoxic trial. Before each trial resting values were obtained
with 43 14 min rest between the trials. The trials included
the following.
(1) The subjects were asked to hyperventilate to reduce
the end-tidal pressure of carbon dioxide (PETCO2; INNOCOR,
Odense, Denmark) by 1.5 kPa. Blood samples were collected
after 7  2 min reflecting when the targeted PETCO2 was
established.
(2) To increase skin temperature, the subjects were ex-
posed to whole-body heating. The subjects were covered
with a heat-isolating aluminum blanket together with a ded-
icated heating blanket (Bair Hugger 505; Arizant Health-
care, Eden Prairie, MN) that was inflated by air at 42°C.
Linens covered and isolated the head. Blood samples were
obtained after 26  7 min, reflecting when there was no
further increase in SBF (skin temperature increased by 1.7
0.7°C) and it was confirmed that PaCO2 remained stable.
(3) Norepinephrine (0.15 g  kg1  min1) was infused
through the central venous catheter for 15 min; blood sam-
ples were collected afterward. To avoid potential effects of
norepinephrine on PaCO2,
7 the subjects were instructed to
restrain the ventilatory depth for 11  5 min in order to
maintain the arterial carbon dioxide. If the subject was not
able to control PETCO2 in this way, a tube was added to the
inspired gas mixture and thus increased the ventilatory death
space. Administration of norepinephrine with and without
PETCO2 correction was performed in randomized order.
(4) After these trials, the subjects were exposed to hypoxia
(FiO2: 0.12%) for which the inspired air was balanced by N2
(Altitrainer, SMTEC, Nyon, Switzerland) for 10 min, while
blood samples were collected.
Statistical Methods
Based on similar studies,7,8,34 a sample size of 15 subjects was
assumed to provide   0.20. One-way ANOVA followed
by a Tukey post hoc test on repeated measures evaluated vari-
ables. To express relationships between variables we used
Pearson’s correlation. The results are presented as changes
from baseline and variables are provided with their 95% CI.
We performed a two-tailed hypothesis testing and the statis-
tically significant level was set to P 0.05 with data analyzed
in SAS 9.2 (SAS Institute Inc., Cary, NC). Because of insuf-
ficient signal quality,MCV vmean was excluded in one subject
during hyperventilation and in another subject during the
control before whole-body heating. Similarly, scO2 was ex-
cluded in one subject during whole-body heating.
Results
Hyperventilation
As intended, hyperventilation induced a 1.1 kPa decrease in
PaCO2 whereas PaO2 increased (table 1). Skin oxygen satura-
tion increased by 1.8% (0.5% to 3.1%), although there were
no changes in skin hemoglobin concentrations, skin vascular
resistance index, or SBF.
There were no changes in MAP, but MCA vmean, sjO2,
and CBFFick all decreased. Also, the NIRS-determined scO2
was reduced by 2.1% (0.4–3.7%; fig. 1) and scapO2 was re-
duced by 5.3% (3.8–6.9%).
Whole-body Heating
With exposure to whole-body heating there was an increase
in skin temperature by 1.6°C (0.7–2.6°C) (table 2) and a
concomitant increase in SBF by 23.5 AU (10.4–36.6) and
skin oxygen saturation by 3.1% (1.3–4.9%).
We did not observe any changes in MAP, MCA vmean,
sjO2, or CBFFick in response to whole-body heating (table 1).
Yet, there was an increase by 3.6% (2.1–5.1%; fig. 1) in scO2,
whereas scapO2 remained unchanged.
Administration of Norepinephrine
With administration of norepinephrine, skin vascular resis-
tance index increased while total hemoglobin of the skin
decreased (table 2). Thus, skin oxygen saturation was re-
duced by 2.2% (1.0–4.3%).
Administration of norepinephrine induced in average 22
mmHg increase in MAP, whereas MCA vmean, sjO2, and
CBFFick were unaffected. Yet, the scO2 was reduced by 6.2%
(4.2–8.0%; fig. 2), although scapO2 remained unchanged.
PERIOPERATIVE MEDICINE
Anesthesiology 2012; 117:263–70 Sørensen et al.265
Administration of Norepinephrine with PETCO2 Correction
The subjects managed to keep PaCO2 at the level established
before administration of norepinephrine, eventually with en-
largement of the ventilatory dead space (n 6). Under these
circumstances there was a tendency for a reduction in skin
oxygen saturation (3.8–0.5%; P 0.066), but no changes
in SBF or skin temperature, although skin hemoglobin con-
centrations and skin vascular resistance index were affected
(table 2).
The MCA vmean increased by 6.9 cm/s. With PETCO2
correction, scO2 remained reduced by 4.2% (2.2–6.0%; fig.
2) with no change in scapO2 (3.7–4.9%).
Hypoxia
Hypoxia was associated with a reduction in skin oxygen sat-
uration by 8.9% (6.3–11.6%; fig. 2). There was an increase
in skin vascular resistance index because SBF decreased (table
2), but, on the other hand, skin hemoglobin concentrations
remained unaffected.
With hypoxic exposure, PaO2 and saO2 were reduced.
Neither MCA vmean nor CBFFick changed. Also scO2 (by
10.2%; 6.6–13.7%) and scapO2 (by 7.9%; 6.4–9.4%; fig. 1)
were reduced.
Discussion
The results provide, in our opinion, compelling evidence
that skin oxygen saturation affects the applied spatially re-
solved INVOS NIRS-determined evaluation of scO2.
Whole-body heating and administration of norepinephrine
provide a discrepancy between the increase respectively re-
duction in scO2 despite stability in scapO2. On the other hand,
Table 1. Systemic and Cerebral Hemodynamics
Units of Measure saO2 % scO2 % scapO2 % sjO2 %
PaO2
kPa
PaCO2
kPa
CVRi
mmHg ·
cm1 · s1
MCA vmean
cm/s
CBFFick
AU
MAP
mmHg
Control 98.3  0.4 77.5  5.4 81.4  2.5 64.4  4.8 13.7  0.9 5.4  0.3 2.0  0.7 57.0  16.6 32  5 102.0  10.9
NE 98.8  0.3† 72.4  7.3‡ 81.1  3.3 63.4  6.5 14.5  0.7† 5.0  0.3‡ 2.4  0.8* 55.7  14.7 28  5* 123.2  13.6‡
NE  CO2 98.3  0.6 74.0  5.9† 83.4  3.7 68.4  7.7 13.7  1.0 5.4  0.3 2.2  0.8 62.9  20.7* 38  2 122.8  11.6‡
Hyperventilation 99.2  0.4‡ 76.1  6.8* 76.4  4.8‡ 53.6  9.8‡ 15.9  1.4‡ 4.4  0.7‡ 2.3  0.6* 48.1  11.1† 25  1‡ 102.6  9.1
WBH 98.4  0.4* 80.0  5.1† 81.9  4.0 65.3  7.9 14.0  0.7* 5.4  0.2 2.0  0.9 56.0  16.2 34  1 102.0  20.6
Hypoxia 91.8  3.7‡ 68.0  10.7‡ 73.1  3.7‡ 54.0  4.5‡ 8.7  2.6‡ 4.7  0.4* 1.8  0.5 54.8  12.3 29  3 91.1  14.9*
Systemic and cerebral hemodynamics with hyperventilation, whole-body heating, hypoxia (fiO2  0.12%), and administration of
norepinephrine (0.15 g · kg1 · min1) with and without PETCO2 correction.
* P  0.05. † P  0.01. ‡ P  0.001.
CBF  cerebral blood flow; CVRi  cerebrovascular resistance index; MAP  mean arterial pressure; MCA vmean  mean velocity of
the middle cerebral artery; NE administration of norepinephrine; NE CO2 administration of norepinephrine with PETCO2 correction;
saO2  arterial oxygen saturation; scapO2  calculated average cerebral oxygen saturation; sco2  NIRS-derived cerebral oxygen
saturation; sjO2  internal jugular venous oxygen saturation; WBH  whole-body heating.
Fig. 1. Changes in cerebral oxygen saturation, skin oxygen saturation, and calculated average cerebral oxygen saturation during
whole-body heating, hyperventilation, and hypoxia. Error bars represent 95% CI limits. P values for the intervention are
presented. scO2  cerebral oxygen saturation; scapO2  calculated average cerebral oxygen saturation; sskinO2  skin oxygen
saturation.
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during hyperventilation and hypoxia, there were corre-
sponding reductions in scO2 and scapO2. Thus, the reduc-
tion in scO2 during administration of norepinephrine can
be explained by cutaneous vasoconstriction, whereas the
increase in scO2 during whole-body heating seems because
of an increase in skin oxygen saturation. These observa-
tions have implications for use of NIRS clinically and for
preservation of scO2 and in turn CBF with administration
norepinephrine during anesthesia.
The calculation of cerebral oxygenation from arterial and
jugular bulb saturation is of importance to this study. Here,
we used an approach based on cerebral oxygen extraction and
defined the average cerebral blood hemoglobin oxygenation
as the midway point between the arterial and jugular venous
saturations.29 Others have proposed a 3:1 ratio primarily
based on anatomical evidence between arterial and venous
blood for validation of NIRS.35 The contribution ratio may
be different between NIRS devices and it is unlikely that the
composition of cerebral blood volume remains stable at dif-
ferent levels of PcO2 and, consequently, CBF.
1,36 The NIRS-
derived arterial-to-venous ratios are somewhat contradicted
by positron emission tomography data,37 but contribution
from skin may have influenced NIRS validation of the cere-
bral blood volume distribution. Importantly, using a 3:1
ratio between arterial and venous blood, or sjugO2 alone, does
not change the conclusion that skin has a significant contri-
bution to the NIRS signal.
Vasodilation of the Skin
The penetration depth sensitivity of NIRS light is propor-
tional to the emitter-detector separation.24 The presented
results raise the questionwhether a separation distance of 3 or
4 cm is enough to secure spatial resolution and thereby ex-
clude crosstalk between scO2 and skin oxygen saturation.
With whole-body heating, we obtained an increase in scO2
and skin oxygen saturation, whereas calculated scapO2 re-
mained stable (fig. 1). Thus, the increase in scO2 associated
with whole-body heating can be explained by the increase in
skin oxygen saturation. Nonspatially resolved NIRS is af-
fected by skin oxygen saturation with local and whole-body
heating13 and with intradermal injections of epinephrine.14
Here, with spatially resolvedNIRS, we observed a correlation
between scO2 and skin oxygen saturation during administra-
tion of norepinephrine with and without PETCO2 correction-
(fig. 2) and a similar correlation was observed during whole-
body heating (fig. 3). In support for an influence of skin
Table 2. Skin-derived Variables
Units of Measure
Skin Oxygen
Saturation
%
Total
Hemoglobin
of Skin
AU
Oxyhemoglobin
of Skin
AU
Deoxyhemoglobin
of the Skin
AU
Vascular
Resistance
mmHg/cm/s
Skin
Blood
Flow
AU
Skin
Temperature
°C
Control 57.0  7.0 14.8  8.8 8.6  5.3 6.2  3.9 1.5  0.5 73  21 33.7  0.9
NE 54.5  8.4* 10.7  6.6* 5.8  3.2* 4.9  3.7* 1.9  0.7‡ 73  26 33.7  0.9
NE  CO2 54.4  7.6 11.2  8.2* 6.3  4.5* 5.0  3.9* 1.9  0.7† 73  22 33.9  0.8
Hyperventilation 58.3  7.1* 15.5  7.2 9.3  4.7 6.2  3.0 1.6  0.6 74  24 33.8  0.8
WBH 60.7  7.8† 14.7  6.2 9.2  3.9 5.5  2.8 1.2  0.6† 95  34† 35.5  0.7‡
Hypoxia 49.8  8.8* 15.5  8.1 8.2  5.4 7.3  3.2 1.8  0.5† 60  23† 32.7  1.4‡
Skin hemodynamics with hyperventilation, whole-body heating, hypoxia (fiO2  0.12%), and administration of norepinephrine (0.15 g
· kg1 · min1) with and without PETCO2 correction.
* P  0.05. † P  0.01. ‡ P  0.001.
NE  administration of norepinephrine; NE  CO2  administration of norepinephrine with PETCO2-correction; WBH  whole-body
heating.
Fig. 2. (A) Changes in cerebral oxygen saturation, skin oxy-
gen saturation, and calculated average cerebral oxygen sat-
uration during administration of norepinephrine (0.15 g 
kg1  min1) with and without PETCO2 correction. Error bars
represent 95% CI limits and P values for the intervention are
presented. (B) Correlation of cerebral oxygen saturation with
both calculated average cerebral oxygen saturation and skin
oxygen saturation, during administration of norepinephrine
with and without PETCO2 correction. scO2  cerebral oxygen
saturation; scapO2  calculated average cerebral oxygen sat-
uration; sskinO2  skin oxygen saturation.
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oxygen saturation on scO2, a marked increase in SBF and
reduced skin vascular resistance index were observed.
Marked hyperthermia can elicit hyperventilation, but
PaCO2 was maintained during whole-body heating and
therefore did not affect cerebrovascular resistance index
and sjO2 as previously described.
1 Core temperature was
not recorded, but the results show no changes in PaCO2,
MCA vmean, or CBFFick, typically seen during whole-body
heating.9
Vasoconstriction of the Skin
Previous studies suggest that administration of vasopressors
exert a negative impact on scO2.
5–7 It is debated whether the
reduction in scO2 is because of a decrease in cardiac output,
38
sympathetically mediated cerebral vasoconstriction, or
changes in SBF.34 It is less ambiguous how -adrenergic
drugs affect the microcirculation of the skin.39 The present
results demonstrate a decrease in skin oxygen saturation with
administration of norepinephrine (fig. 2) and lower skin he-
moglobin concentrations and increased skin vascular resis-
tance index. At the same time, scO2 decreased whereas calcu-
lated scapO2 was unaffected, suggesting that cutaneous
vasoconstriction affects the NIRS-determined scO2. In sup-
port, when PETCO2 was maintained, the reductions in scO2
and skin oxygen saturation remained and the reduction in
scO2 during administration of norepinephrine could illus-
trate the influence of skin oxygen saturation considering that
scapO2 was stable.
Administration of phenylephrine provokes a marked re-
duction in scO2 despite unaffected internal carotid artery
flow, PaO2 and PaCO2.
34 We acknowledge that a decrease in
scO2 with administration of norepinephrine could be because
of an alteration in the arterial and venous contributions to
the NIRS signal, but also, cutaneous vasoconstriction could
be responsible for the reduction in scO2. Administration of
ephedrine, on the other hand, does not affect scO2.
5–7 One
explanation for this discrepancy could be that ephedrine does
not have the same vasoconstrictive effects on smoothmuscles
in skin vasculature as norepinephrine. Reduction in cardiac
output has a negative impact on scO2,
40 but the present re-
sults suggest that the reduction in scO2 is explained by a
reduction in skin oxygen saturation. The stability of MCA
vmean and CBFFick also emphasize that cerebral blood flow is
not challenged, which would have been the case if cardiac
output was lowered.40 It remains unknown to what extent
the cerebral vasculature is influenced by sympathetic inner-
vation, but the results do not support sympathetic vasocon-
striction in brain (table 1).
Hypoxia and Hypocapnia
With systemic hypoxic exposure, scapO2 was reduced by 7.9%
and scO2 by 10.2% (P  0.0001). Therefore, it seems that
NIRS estimates brain oxygen saturation correctly during sys-
temic hypoxic exposure. The influence of the skin oxygen
saturation is minimal with hypoxia, but we cannot exclude
that the 2.3% discrepancy between scO2 and scapO2 can be
explained by the 8.9% reduction of skin oxygen saturation
(P  0.03) because of cutaneous vasoconstriction (table 2).
The threshold for hypoxemia-induced arterial dilatation was
not reached,41 but we cannot exclude cerebral vasodilatation
because of hypoxic exposure. On the other hand, such vaso-
dilation was likely counterbalanced by hypocapnia, because
MCV vmean did not change significantly (table 1).
Because of the higher oxygen pressure during hyperven-
tilation, skin oxygen saturation increased, whereas scapO2 and
scO2 decreased (fig. 1).The inverse relationship between scO2
and skin oxygen saturation with hyperventilation could ex-
plain why scO2 underestimates scapO2 by 3.2%, however, sys-
tematic errors because of a low signal-noise ratio cannot be
excluded. These findings support that PaCO2 has an influence
on cerebral oxygen saturation as assessed by NIRS11 and
more so than the influence of the skin oxygen saturation.
Regardless of the crosstalk between skin oxygen saturation
and scO2, INVOS is sensitive to changes in cerebral oxygen
saturation during hyperventilation and systemic hypoxic
exposure.
Perspective
Despite the influence of SBF for the NIRS signal, it remains
useful for perioperative optimizing to improve patient out-
come after anesthesia,2,25 although administration of -ago-
nists as vasopressors may confound interpretation of NIRS.
Further studies are needed to evaluate whether difference in
emitter-detector separation of more than 3 and 4 cm can
avoid crosstalk between skin oxygen saturation and spatially
resolved scO2. Alternatively, different algorithms for the anal-
ysis of NIRS data are required to suppress skin artifacts. In a
multiple regression analysis, skin oxygenation contributes
Fig. 3. Correlation of skin oxygen saturation and cerebral
oxygen saturation during administration of norepinephrine
with and without PETCO2 correction, represented as red dots,
and whole-body heating presented as blue dots. For all data
in the plot, r  0.64 (P  0.0001), with r  0.6 (P  0.0001)
for administration of norepinephrine and r 0.4 (P 0.15) for
whole-body heating. scO2  cerebral oxygen saturation;
sskinO2  skin oxygen saturation.
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approximately 30% to the NIRS signal; however, further
investigations are needed to quantify in details the contribu-
tion from the different components beneath the NIRS sen-
sor. Furthermore, it is needed to evaluate whether adminis-
tration of norepinephrine is associated with reduction in scO2
in situations with low cardiac out or hypotension.
Conclusion
The results suggest that the reduced INVOS NIRS-deter-
mined evaluation of scO2 observed with administration of
norepinephrine is because of skin vasoconstriction rather
than cerebral deoxygenation. Thus, in situations with ad-
ministration of norepinephrine and whole-body heating, an
emitter-detector separation of 3 or 4 cm seems not to be large
enough to avoid crosstalk between skin oxygen saturation
and the INVOS NIRS-determined scO2, and further techni-
cal measures to eliminate the skin contribution should be
considered. Nevertheless, the results confirm that spatial re-
solved NIRS is able to detect cerebral deoxygenation associ-
ated with hyperventilation and systemic hypoxic exposure.
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